ENPAC: phase II trial with safety lead of enzalutamide in combination with paclitaxel and carboplatin for advanced or recurrent endometrioid endometrial adenocarcinomaShannon N. Westin, Robert L. Coleman, Gordon B. Mills et al.|Gynecologic Oncology|2021Cited by 6